Article info

Download PDFPDF
Clinical Significance of Serum CA-125 and Soluble Tumor Necrosis Factor Receptor Type I in Cervical Adenocarcinoma Patients

Authors

  1. Address correspondence and reprint requests to Beata Kotowicz, PhD, Department of Tumor Markers, Cancer Center and Institute of Oncology, 02-781 Warsaw, ul. Roentgena 5, Poland. E-mail: bkotowicz{at}coi.pl.

Citation

Kotowicz B, Kaminska J, Fuksiewicz M, et al
Clinical Significance of Serum CA-125 and Soluble Tumor Necrosis Factor Receptor Type I in Cervical Adenocarcinoma Patients

Publication history

  • Received October 2, 2009
  • First published May 1, 2010.
Online issue publication 
May 01, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.